Evidence map›Paper›PMID 40580264›Full record

ArticleInternational journal of clinical pharmacy2025

Development of a behavioural theory-based New Medicine Service toolkit for community pharmacists to promote medication adherence.

Betul Okuyan, Pınar Ay, Mesut Sancar, Vildan Ozcan, Ozge Durak-Albayrak, Meltem Turker, Arman Uney, Corrine I Voils

Abstract read
In one paragraph

Article in International journal of clinical pharmacy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Trial
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Betul OkuyanDepartment of Clinical Pharmacy, Faculty of Pharmacy, Marmara University, Istanbul, Türkiye. betulokuyan@yahoo.com.
Pınar AyDepartment of Public Health, School of Medicine, Marmara University, Istanbul, Türkiye.
Mesut SancarDepartment of Clinical Pharmacy, Faculty of Pharmacy, Marmara University, Istanbul, Türkiye.
Vildan OzcanTurkish Pharmacists' Association, Ankara, Türkiye.
Ozge Durak-AlbayrakTurkish Pharmacists' Association, Ankara, Türkiye.
Meltem TurkerTurkish Pharmacists' Association, Ankara, Türkiye.
Arman UneyTurkish Pharmacists' Association, Ankara, Türkiye.
Corrine I VoilsDepartment of Internal Medicine, School of Medicine, University of Utah, Salt Lake City, UT, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionAdherence to newly prescribed cardiometabolic medications is low. It is crucial to develop personalized behavioural interventions to address patients' specific medication adherence barriers.

aimThe aim of this study was to develop a behavioural theory-based New Medicine Service (NMS) toolkit for use by community pharmacists in Türkiye to identify and address reasons for nonadherence in patients newly started on medications for hypertension, diabetes, or dyslipidemia.

methodThis multistage study used a literature search, expert panel, cognitive interviews, and survey with patients to identify reasons for nonadherence to include in the Turkish DOSE Nonadherence Scale. A short form of the toolkit was generated by asking the patients to select the most challenging reasons for nonadherence. To identify relevant pharmacist interventions, the theoretical domains framework (TDF-14) (v2) domains related to reasons for nonadherence were identified and matched with behavioural change techniques (BCTs). To assess the applicability of the proposed pharmacist interventions in daily practice, an online survey of community pharmacists was conducted using a modified Delphi study.

resultsThe final list of reasons for nonadherence consisted of 31 items, of which 14 identified as most challenging by patients were selected for inclusion in the short form of the NMS toolkit. For the full 31 reasons, ten domains of TDF-14 and 18 BCTs were selected. In the Delphi study (response rate: 83.3%), 68 of the 81 (84.0%) pharmacist interventions were found to be applicable, corresponding to 15 BCTs.

conclusionThe behavioural theory-based NMS toolkit was developed for use by community pharmacists to identify and address reasons for nonadherence in patients newly started on medications to manage hypertension, diabetes, or dyslipidemia. This toolkit will assist community pharmacists in developing personalized interventions to overcome nonadherence problems in patients who are newly starting medications. Future studies should be conducted to assess the impact of this new toolkit on patients' medication adherence levels and clinical outcomes.

Indexed as

Community Pharmacy ServicesMedication AdherencePharmacistsAdultAgedDelphi TechniqueFemaleHumansMaleMiddle AgedProfessional RolePsychological TheorySurveys and QuestionnairesTurkeyAssessment of medication adherenceBehaviour change techniquesCardiometabolicCardiovascular diseasesDiabetes mellitusNonadherence, adherence interventionsTheoretical domains framework

Identifiers

PMID40580264
PMCPMC12630297

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.